Home News & Events Events Webinars Webinars Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Category BiotechCardiovascularCell and Gene TherapiesDigital DisruptionEarly ClinicalInfectious DiseaseInternal Medicine & ImmunologyLaboratoriesMedical ImagingOncologyPediatricsPatient CentricityRare & Orphan DiseasesReal World IntelligenceRegulatory IntelligenceVaccinesValue Based HealthcareWomen's Health Webinars Activity Monitoring, Setting Standards for Clinical Research Date 6 July 2016 Time 16:00 - 17:00 Location Webinar Timezone America/Bogota Webinars Developing an Observer-Reported Outcomes Measure (ObsRO) Date 22 June 2016 Time 11:00 - 12:00 Location Webinar Timezone America/Bogota Using a case study approach, webinar participants will learn more about developing ObsROs and implementing them in clinical studies. We’ll discuss some of the key challenges faced in developing and using an ObsRO, along with potential solutions. Webinars FDA Waivers for TQT Studies Date 8 December 2015 Time 10:00 - 11:00 Location Webinar Timezone America/Lima Previous 1 … 18 19 20 ICON’s Webinar Channel A library of recorded webinars exploring topics ranging from early to late phase. Subscribe Today In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions ICON's Webinar channel Event Workshops Event Industry events What's happening in ICON ICON Plc Thank you to everyone who joined our Rare Disease Day webinar. From gene targeted therapies to accelerated approvals, the inspiring discussion highlighted how patient leadership continues to shape ultra rare disease drug... 17 Mar View post View webpage ICON Plc Missed our Rare Disease Day webinar or want to rewatch the discussion? Hear real world examples of how patient led organisations are breaking barriers in ultra rare disease drug development. Watch the recording today: ht... 17 Mar 1 View post View webpage ICON Plc Join us to explore the latest best practices in global flow cytometry QC and harmonisation. During this webinar hosted by Bioanalysis Zone ICON’s flow cytometry specialists will discuss: - Industry best practices for h... 3 Mar View post View webpage ICON Plc Ultra rare disease progress does not happen by accident. Register for our webinar to hear how patient leaders are accelerating therapies and redefining what is possible through practical, repeatable expert‑proven model... 26 Feb View post View webpage ICON Plc In recognition of Rare Disease Day, join ICON’s Centre for Rare Diseases for an inspiring panel at our upcoming webinar on 3 March at 11 am EST. Hear directly from parent and patient leaders whose advocacy is driving f... 24 Feb View post View webpage ICON Plc How do patient-led organisations help bring therapies to families faster? Our live webinar gathers relentless leaders to explore real world examples of patient-led innovation reshaping drug development and regulatory str... 18 Feb 2 View post View webpage ICON Plc When patients lead, progress follows. Join ICON’s Centre for Rare Diseases for a special Rare Disease Day webinar exploring how patient and parent leaders are breaking barriers in ultra rare disease drug development. F... 12 Feb View post View webpage ICON Plc Missed our recent webinar from Symphony Health, an ICON plc company? The recording for Riding the data wave: How pharma can navigate disruptions in open claims is now available. Discover how life sciences organisatio... 16 Jan View post View webpage ICON Plc Early phase neurodegenerative trials require careful planning, a patient-first approach, and biomarker strategies that drive progress. Tune in to our recent ASCPT-hosted webinar, where we explored: - How to define target... 18 Dec View post View webpage ICON Plc USP compounding may be fast — but is it costing you quality, compliance, and insight? In this insightful session, our experts discussed: - Why GMP manufacturing offers a strategic edge in early phase trials - Real-worl... 17 Dec View post View webpage
